Perspective Therapeutics (CATX)

• Market cap: $154M
• 1 day: 0.48%
• 5 days: -7.56%
• 1 month: -57.02%
• 3 months: -46.67%
• 6 months: -3.7%
• Year to date: -37.16%
• 1 year: -76.68%
• 5 years: -44.09%
• 10 years: -83.36%
• Sector: Healthcare
• Industry: Medical Instruments & Supplies

About: Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.

Employees: 140